Literature DB >> 25713144

Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.

Xin Huang1, Jian Zhou2, Aiwu Zhou3, Steven T Olson2.   

Abstract

The anticoagulant serpin, protein Z-dependent protease inhibitor (ZPI), circulates in blood as a tight complex with its cofactor, protein Z (PZ), enabling it to function as a rapid inhibitor of membrane-associated factor Xa. Here, we show that N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-3-oxa-1,3-diazol-4-yl)ethylenediamine (NBD)-fluorophore-labeled K239C ZPI is a sensitive, moderately perturbing reporter of the ZPI-PZ interaction and utilize the labeled ZPI to characterize in-depth the thermodynamics and kinetics of wild-type and variant ZPI-PZ interactions. NBD-labeled K239C ZPI bound PZ with ∼3 nM KD and ∼400% fluorescence enhancement at physiologic pH and ionic strength. The NBD-ZPI-PZ interaction was markedly sensitive to ionic strength and pH but minimally affected by temperature, consistent with the importance of charged interactions. NBD-ZPI-PZ affinity was reduced ∼5-fold by physiologic calcium levels to resemble NBD-ZPI affinity for γ-carboxyglutamic acid/EGF1-domainless PZ. Competitive binding studies with ZPI variants revealed that in addition to previously identified Asp-293 and Tyr-240 hot spot residues, Met-71, Asp-74, and Asp-238 made significant contributions to PZ binding, whereas Lys-239 antagonized binding. Rapid kinetic studies indicated a multistep binding mechanism with diffusion-limited association and slow complex dissociation. ZPI complexation with factor Xa or cleavage decreased ZPI-PZ affinity 2-7-fold by increasing the rate of PZ dissociation. A catalytic role for PZ was supported by the correlation between a decreased rate of PZ dissociation from the K239A ZPI-PZ complex and an impaired ability of PZ to catalyze the K239A ZPI-factor Xa reaction. Together, these results reveal the energetic basis of the ZPI-PZ interaction and suggest an important role for ZPI Lys-239 in PZ catalytic action.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Anticoagulant; Coagulation Factor; Factor Xa; Kinetics; Protease; Protease Inhibitor; Protein Z; Serpin; ZPI

Mesh:

Substances:

Year:  2015        PMID: 25713144      PMCID: PMC4392287          DOI: 10.1074/jbc.M114.633479

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Prothrombotic phenotype of protein Z deficiency.

Authors:  Z F Yin; Z F Huang; J Cui; R Fiehler; N Lasky; D Ginsburg; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  The risk of occurrence of venous thrombosis: focus on protein Z.

Authors:  Valeria Bafunno; Rosa Santacroce; Maurizio Margaglione
Journal:  Thromb Res       Date:  2011-08-31       Impact factor: 3.944

3.  Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.

Authors:  Ewa Sierko; Marek Z Wojtukiewicz; Lech Zimnoch; Piotr Tokajuk; Krystyna Ostrowska-Cichocka; Walter Kisiel
Journal:  Thromb Res       Date:  2011-11-17       Impact factor: 3.944

4.  Quantitative evaluation of the contribution of ionic interactions to the formation of the thrombin-hirudin complex.

Authors:  S R Stone; S Dennis; J Hofsteenge
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

5.  Primary structure of vitamin K-dependent human protein Z.

Authors:  H Sejima; T Hayashi; Y Deyashiki; J Nishioka; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

6.  Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.

Authors:  S D Lewis; P P Shields; J A Shafer
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

7.  Protein Z influences the prothrombotic phenotype in Factor V Leiden patients.

Authors:  Bettina Kemkes-Matthes; Margareta Nees; Gitta Kühnel; Axel Matzdorff; Karl J Matthes
Journal:  Thromb Res       Date:  2002-05-15       Impact factor: 3.944

8.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

9.  Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.

Authors:  A Tabatabai; R Fiehler; G J Broze
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

10.  Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.

Authors:  T J Girard; N M Lasky; E A Tuley; G J Broze
Journal:  J Thromb Haemost       Date:  2013-02       Impact factor: 5.824

View more
  5 in total

Review 1.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

2.  Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.

Authors:  Xin Huang; Richard Swanson; Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2019-03-27       Impact factor: 5.157

3.  Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.

Authors:  Xin Huang
Journal:  J Thromb Haemost       Date:  2019-09-05       Impact factor: 5.824

4.  Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity.

Authors:  Tanusree Sengupta; Narayanan Manoj
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

5.  Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.

Authors:  Xin Huang; Richard Swanson; Steven T Olson
Journal:  J Biol Chem       Date:  2022-05-10       Impact factor: 5.486

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.